Travere Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of TVTX for the last quarter is 54.12 M USD, and it's 30.80% higher compared to the previous quarter. The net income of Q2 24 is -70.41 M USD.